BPC-157 10mg · Research brief
How to Verify a Peptide Supplier's COA: Step by Step
Short answer
Verify a peptide supplier's certificate of analysis by doing four things in order: confirm the document names an independent third-party laboratory with reachable contact details, match the batch or lot number on the COA to the number printed on the vial you actually received, check that every purity claim is tied to a named analytical method with the supporting chromatogram…
How do I verify a peptide supplier's COA?
Verify a peptide supplier's certificate of analysis by doing four things in order: confirm the document names an independent third-party laboratory with reachable contact details, match the batch or lot number on the COA to the number printed on the vial you actually received, check that every purity claim is tied to a named analytical method with the supporting chromatogram attached, and confirm the test date belongs to the batch in your hands rather than an older run. If any of those four links break, the document proves nothing. A COA you cannot trace back to a specific lab and a specific lot is a marketing asset, not a quality record.
For a business buyer (a med spa owner, a clinic operator, a telehealth founder, or a reseller building a catalog), this matters more than it does for an individual purchaser. You are putting your own brand name in front of the product. The supplier's testing becomes your quality story by default, so the document behind it has to hold up under scrutiny from your customers, your insurer, and your counsel.
What a certificate of analysis is actually supposed to prove
A COA is a lab-issued record describing what was found in a defined quantity of material at a defined moment in time. That last part is where most confusion starts. A COA does not certify a supplier, a brand, or a compound in general. It certifies one batch. The moment a new synthesis run happens, the previous COA stops describing what is in the bottle.
At minimum, a usable document identifies the compound, states the lot or batch number, gives the date of analysis, names the testing laboratory, describes the analytical methods used, and reports results against stated specifications. Anything less is a summary, and summaries are trivially easy to produce in a word processor.
It is also worth being clear about scope. Research peptides are supplied for laboratory and research use only. They are not FDA-approved drugs, and a COA is not a safety document, a clearance, or an approval of any kind. It reports analytical findings (purity, identity, contaminant screens) and nothing beyond that.
Reading the document line by line
Most buyers glance at the purity number and move on. The purity number is the least informative part of the page, because it means nothing without the method and the chromatogram behind it. Here is how a complete record differs from a thin one.
| Element | Verifiable COA | Thin or decorative COA |
|---|---|---|
| Lot / batch number | Unique, printed on the vial, matches the file | Absent, generic, or reused across products |
| Testing laboratory | Named, with address and contact details | Unnamed, or vaguely 'third-party verified' |
| Analytical methods | Stated per test (HPLC, MS, and so on) | Results with no method listed |
| Chromatogram | Attached, readable, with peak data | Missing, cropped, or a low-resolution image |
| Date of analysis | Specific and tied to the batch | Undated, or years older than the stock |
| Specification limits | Pass or fail against a stated threshold | Numbers with no thresholds to compare against |
| Contaminant panels | Multiple screens reported individually | A single purity figure standing alone |
The chromatogram is the part worth learning to read even at a basic level. You do not need to be an analytical chemist. You need to see that a chromatogram exists, that the main peak dominates the trace, and that the reported purity figure plausibly corresponds to what the trace shows. A purity claim with no chromatogram attached is an assertion, not a measurement.
Tracing the document back to the laboratory that issued it
This is the step that separates real verification from document review. Find the laboratory named on the COA and confirm it exists independently of the supplier. A legitimate contract lab has a website, a physical address, and a phone number that reaches a human. Many will confirm whether they issued a report bearing a given reference number, though policies on what they will disclose to third parties vary.
Ask the supplier directly whether testing is in-house, third-party, or both. In-house testing is not automatically disqualifying, many manufacturers run their own quality control in addition to outside verification, but a supplier that presents in-house results as third-party validation has already told you something about how they handle the truth.
Watch for the distinction between a lab that is accredited to a recognised standard and one that simply describes itself as certified. Accreditation is issued by a specific body against a specific standard and can usually be checked. Marketing language cannot. When a supplier will not name the lab at all, treat the COA as unverifiable and price the risk accordingly.
Wholesale Partner Program
Stock Real Peptides at your business
- 99%+ HPLC purity
- 7-panel testing, COAs you can verify
- 5–7 day US fulfillment
Batch matching: the step almost everyone skips
A supplier can hand you an immaculate, fully traceable COA for a batch that has nothing to do with the vials in your shipment. This is not exotic. It is the single most common way a technically genuine document becomes misleading.
When product arrives, read the lot number off the label and compare it character by character to the lot number on the document you were given. If they do not match, ask for the correct one before the stock goes anywhere near your shelves. If the vials carry no lot number at all, there is nothing to match, and no COA in the world can be tied to what you received.
Build this into receiving rather than treating it as an occasional spot check. One person, one checklist, one place where COAs are filed against purchase orders. When a customer, an insurer, or a regulator asks what documentation you hold on a given lot, you want that answer to take thirty seconds.
Beyond purity: the panels that get quietly omitted
Purity by HPLC tells you what proportion of the material is the target compound. It does not tell you what the remainder is, and it does not screen for the contaminant classes that matter most in a manufacturing context. A more complete testing package generally covers several distinct areas: identity confirmation (typically by mass spectrometry), purity, water or moisture content, residual solvents left over from synthesis, heavy metals, bacterial endotoxins, and microbial or bioburden screening.
A supplier reporting one number across a whole catalog is testing narrowly, whichever way they describe it. Ask which panels are run on every batch versus which are run periodically or on request. Ask whether COAs are published openly or produced only when a buyer pushes. Some operations charge for the document, or release it only after purchase, a practice worth weighing carefully, since a quality record that costs extra is being treated as a product rather than as a baseline.
Red flags that justify walking away
Certain patterns come up often enough to be worth naming. An identical purity figure on every compound in a catalog suggests a template, not a lab. A COA with the supplier's own branding and no laboratory identification is self-certification wearing a lab coat. Missing or illegible chromatograms, undated reports, lot numbers that repeat across unrelated products, and refusal to name the testing facility all point the same direction.
So does opacity in adjacent areas. Suppliers who hide wholesale pricing behind an unnecessary sales process, who cannot state their minimums plainly, or who describe research compounds in therapeutic language are telling you how the rest of the relationship will go. Compounds supplied for research use should be described as such, consistently, without hedging toward human application.
One further note, and it is a genuine one rather than boilerplate: nothing here is legal advice. Whether and how your business may purchase, hold, or resell research compounds depends on your business structure, your professional licensing, and rules that differ meaningfully between jurisdictions. Those are questions for your attorney and, where applicable, your state licensing board, not questions a supplier or an article should answer for you. What a good supplier can do is give you documentation clean enough that your counsel has something real to work with.
What Real Peptides does differently
Real Peptides tests to 99%+ HPLC purity and runs seven-panel batch testing, with results published as publicly verifiable COAs. That last word carries the weight. The lab documentation is available for the reader to check independently rather than being furnished on request, sold separately, or summarised into a badge. If you want to audit a supplier before you ever speak to one, published COAs are what make that possible; you can pull the record for a catalog item such as BPC-157 10mg or work across the broader popular peptides collection and evaluate the documentation on its own terms.
Wholesale pricing is structured rather than negotiated in the dark, fulfillment runs from the US in five to seven days, and the Wholesale Partner Program application is three steps. For a buyer comparing suppliers, the practical test is simple: how much can you verify before anyone asks you for money? With published COAs and visible program mechanics, most of the diligence described in this article can be completed before a first conversation.
All compounds are supplied for laboratory and research use only. They are not for human consumption, are not FDA-approved drugs, and are not represented as treating anything. Research on individual peptides varies widely in maturity (some compounds have substantial published literature behind them, others very little) and honest suppliers describe that landscape accurately rather than filling the gaps with claims.
Where a qualified buyer goes from here
If you are stocking research compounds under your own brand and you want documentation you can hand to your counsel, your insurer, or a customer without qualification, the next step is straightforward: review the published lab results for the compounds you plan to carry, confirm the batch-matching process meets your receiving standards, and submit an application to the Wholesale Partner Program. Qualified businesses (med spas, clinics, wellness centers, telehealth operators, and resellers) are reviewed through the three-step process, with pricing tiers and terms laid out before commitment rather than after.
More detail on program structure and pricing tiers is available on the wholesale peptides program page, and businesses ready to begin can apply for a wholesale account directly.
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add vials.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA